```html

Warts (Human Papillomavirus Infection) – Comprehensive Medical Guide

Overview

Warts are benign growths of the skin caused by infection with certain types of human papillomavirus (HPV). Over 100 HPV genotypes have been identified; roughly 30 of them are known to cause cutaneous warts, while others infect the anogenital region and mucosal surfaces.

Anyone can develop warts, but they are most common in:

• Children and adolescents (peaks at ages 5‑15)
• Young adults, especially those with weakened immune systems

According to the CDC, about 10‑30% of the general population will develop a wart at some point in their life. In the United States, an estimated 7–10 million people have common warts each year.

Symptoms

The clinical presentation varies with the type of wart and its location. Below is a comprehensive list of symptoms.

Common (Verruca Vulgaris) Warts

• Appearance: Rough, raised, grainy papules usually 1–5 mm in diameter.
• Location: Hands, fingers, elbows, and knees.
• Surface: May have tiny black dots (thrombosed capillaries) that look like “pinheads.”

Flat (Verruca Plana) Warts

• Flat or slightly raised, skin‑colored lesions.
• Often appear in clusters on the face, neck, wrists, or knees.
• More common in children and adolescents.

Plantar Warts

• Located on the soles of the feet; may be painful when walking.
• Often have a callus‑like appearance with a central black dot.

Filiform Warts

• Long, thin, finger‑like projections.
• Typically found on the eyelids, lips, neck, or under the breast.

Periungual Warts

• Develop around fingernails or toenails.
• Can cause nail dystrophy or pain.

Genital Warts (Condyloma Acuminata)

• Soft, fuzzy, cauliflower‑like growths on the vulva, vagina, cervix, penis, scrotum, or anus.
• May be asymptomatic or cause itching, burning, bleeding, or pain during intercourse.

Other Possible Signs

• Occasional itching or mild tenderness.
• Secondary bacterial infection if the wart is scratched or traumatized (redness, swelling, pus).

Causes and Risk Factors

Warts are caused by direct skin‐to‐skin contact with HPV particles. The virus penetrates the outermost layer of the skin (stratum corneum) through tiny cuts, abrasions, or even microscopic breaks.

Key Causes

• HPV infection: Types 1, 2, 4, 27, and 57 are most commonly linked to cutaneous warts; types 6 and 11 cause most genital warts.
• Viral persistence: Once infected, the virus can remain dormant for months before a wart becomes visible.

Risk Factors

• Age: Children and teenagers have the highest incidence.
• Immune status: Immunosuppression (e.g., HIV, organ transplant, chemotherapy) dramatically raises risk.
• Skin trauma: Cuts, macerated skin, or chronic moisture (e.g., swimmers, athletes) facilitate entry.
• Close contact environments: Day‑care centers, schools, gyms, and communal showers increase transmission.
• Sexual activity: For genital warts, unprotected sexual contact is the main route.
• Smoking: Tobacco use impairs local immune responses, raising the chance of persistent infection.

Diagnosis

Diagnosis of warts is primarily clinical—based on visual inspection and history. In most cases no laboratory tests are required.

Physical Examination

• Clinician examines size, shape, texture, location, and presence of black dots.
• Dermatoscopy may be used to better view vascular patterns.

When a Biopsy Is Considered

• Atypical appearance or rapid change that raises suspicion for squamous cell carcinoma.
• Persistent lesions that do not respond to standard therapy.

Laboratory Tests (Rarely Needed)

• HPV DNA testing: Usually reserved for genital warts or cervical screening (Pap smear).
• Histopathology: Confirms wart architecture (koilocytosis) if a biopsy is performed.

Treatment Options

Because warts are benign, treatment is often optional. Many resolve spontaneously within 2 years, especially in children. However, treatment may be desired for cosmetic reasons, pain, functional impairment, or to prevent spread.

Topical Medications

• Salicylic Acid (SA): 17‑40% concentrations in pads, gels, or ointments. Works by desquamating the infected epidermis. Apply daily after soaking the wart for 5‑10 minutes. Evidence: Systematic reviews (Cochrane 2020) demonstrate 50‑70% clearance after 12 weeks.<sup>1</sup>
• Imiquimod 5% cream: Immune response modifier; stimulates interferon‑α. Used mainly for genital warts. Requires 3‑5 applications per week for up to 16 weeks.
• Podophyllotoxin: Topical antimitotic; effective for anogenital warts (0.5% solution or gel). Contraindicated on mucosal surfaces other than genital skin.

Cryotherapy

Application of liquid nitrogen (-196 °C) to freeze the wart (usually 15‑20 seconds). One to three sessions spaced 2‑3 weeks apart achieve clearance in ~60‑70% of cases.<sup>2</sup>

Electrosurgery & Curettage

• Electrofulguration or electrodessication destroys wart tissue with electric current.
• Curettage involves scraping the wart after local anesthesia.
• Often combined (electro‑curettage) for higher success rates (~80‑90%).

Laser Therapy

Pulsed‑dye laser or CO₂ laser ablation vaporizes wart tissue. Reserved for resistant lesions or facial warts where scarring must be minimized.

Immunotherapy

• Intralesional Candida antigen or MMR vaccine: Stimulates a systemic immune response; useful for multiple or recurrent warts.
• Systemic retinoids (e.g., acitretin): Occasionally prescribed for extensive, refractory cutaneous warts in immunocompromised patients.

Lifestyle & Home Measures

• Keep the area clean and dry.
• Avoid picking or biting warts to reduce autoinoculation.
• Cover large or painful warts with waterproof dressings to curb spread.

Living with Warts (Human papillomavirus infection)

Even after successful treatment, HPV can linger in skin cells, so recurrence is possible.

Daily Management Tips

• Hand hygiene: Wash hands with soap and water after touching warts.
• Foot care: Use separate towels for feet; wear shower shoes in communal areas.
• Protective barriers: Apply waterproof bandages to plantar warts before swimming or exercising.
• Avoid sharing personal items: Towels, razors, nail clippers, and socks.
• Monitor for changes: Note any growth, pain, bleeding, or color change and report to a clinician.

Psychosocial Considerations

Visible warts, especially on the face or genitals, can cause embarrassment or anxiety. Counseling, support groups, or referral to a mental‑health professional is appropriate when distress interferes with daily life.

Prevention

Because HPV is highly contagious, primary prevention focuses on reducing exposure and enhancing host immunity.

• Vaccination: The 9‑valent HPV vaccine (Gardasil 9) protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. While it does not cover all wart‑causing types, it dramatically reduces genital warts (up to 90% efficacy) and high‑risk cancers. Routine vaccination is recommended at ages 11‑12, with catch‑up through age 26 (CDC).
• Hand and foot hygiene: Regular washing, thorough drying, and use of antifungal foot powders in athletes.
• Barrier protection: Wear gloves when handling communal equipment, and use condoms for genital HPV protection (though not 100% effective).
• Avoid skin injury: Keep cuts clean, avoid excessive manicuring or pedicuring that creates micro‑trauma.
• Stay healthy: Adequate sleep, balanced diet, and smoking cessation support immune clearance of HPV.

Complications

While most warts are harmless, complications can arise.

• Secondary bacterial infection: From scratching or breakdown of skin; may need antibiotics.
• Pain or functional limitation: Plantar warts can impede walking; periungual warts may affect nail growth.
• Scarring: Aggressive removal techniques can leave permanent marks, especially on the face.
• Malignant transformation: Rarely, certain high‑risk HPV types (e.g., 16, 18) can lead to squamous cell carcinoma in the anogenital region or oropharynx. This is why persistent genital warts should be evaluated.
• Psychological impact: Social stigma, reduced self‑esteem, and sexual dysfunction in patients with genital warts.

When to Seek Emergency Care

References

1. Cochrane Review: “Topical treatments for cutaneous warts.” 2020. Cochrane Library.
2. American Academy of Dermatology. “Cryotherapy for wart removal.” 2022. AAD.org.
3. CDC. “Genital HPV and Warts.” Updated 2023. CDC.gov.
4. Mayo Clinic. “Warts (cutaneous).” 2022. MayoClinic.org.
5. World Health Organization. “Human papillomavirus (HPV) and cervical cancer.” 2021. WHO.int.

```